New drug targets considered for erectile dysfunction


Paris-Basic research in erectile dysfunction therapy is being hamperedby the attitude of some funding bodies that phosphodiesterase type-5 inhibitorsalone have solved all problems, according to a special committee convenedat the 2nd International Consultation on Erectile and Sexual Dysfunctionshere.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.